Yu Lan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu Lan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Lin Yan
Department of Ultrasound, First Medical Center, Chinese PLA General Hospital
2 shared publications - Mingbo Zhang
Department of Ultrasound, First Medical Center, Chinese PLA General Hospital, Beijing, China
2 shared publications Qing Song
Department of Ultrasound, The First Medical Center Chinese PLA General Hospital, Beijing, People’s Republic of China
2 shared publications- Ying Zhang
From the Departments of Ultrasound (Yan Zhang, W.L., J.H.Z., Ying Zhang, H.Y.H., Y.K.L.) and Pathology (J.L.), Division of First Medical Center, Chinese People’s Liberation Army General Hospital, 28 Fuxing Rd, Beijing 100853, China; and Department of Ultrasound, Division of Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing, China (Y.Y.L.).
2 shared publications - Yukun Luo
Department of Ultrasound, the First Medical Centre Chinese PLA General Hospital Beijing China
2 shared publications - Dongbo Li
Department of Radiology, Inner Mongolia University for Nationalities Affiliated Hospital, Tongliao, China
1 shared publication
Latest Publications
- 21 October 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (10) , 2064-2072
Incremental value of pericarotid adipose tissue radiomics in predicting in-stent restenosis after carotid artery stenting
Objective To evaluate the potential of pericarotid adipose tissue radiomics to improve the prediction of in-stent restenosis (ISR) after carotid artery stenting (CAS). Methods This retrospective study included 191 patients who underwent carotid CT angiography (CTA) and CAS within 1 week at two centers from September 2019 to December 2023. ISR was defined as ≥50% stenosis on follow-up Doppler ultrasound or CTA. Three predictive models were developed and defined as follows: Model A (Clinical), Model B (Clinical + Imaging), and Model C (Clinical + Imaging + Radiomics) using receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis. Results ISR occurred in 44 patients with a mean time interval of 11.3 months. Multivariate Cox regression analyses identified diabetes, fibrinogen, systolic blood pressure, calcified plaque volume, and pericarotid adipose tissue radiomics as independent predictors of ISR. The radiomics score, derived from 15 significant characteristics, outperformed conventional imaging markers. In the training set, Model C (AUC=0.881) significantly outperformed Model A (AUC=0.664) and Model B (AUC=0.840), with statistically significant differences (Model A vs Model C: P=0.001; Model B vs Model C: P=0.0246). This trend was consistent in the validation sets. Calibration curves showed good agreement between predicted and actual ISR probabilities, and decision curve analysis indicated that Model C provided greater net benefits. Conclusion The radiomic characteristics of pericarotid adipose tissue provide incremental value in predicting ISR after CAS and serve as a valuable biomarker for restenosis risk assessment.
- 21 October 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (10) , 2064-2072
Incremental value of pericarotid adipose tissue radiomics in predicting in-stent restenosis after carotid artery stenting
Objective To evaluate the potential of pericarotid adipose tissue radiomics to improve the prediction of in-stent restenosis (ISR) after carotid artery stenting (CAS). Methods This retrospective study included 191 patients who underwent carotid CT angiography (CTA) and CAS within 1 week at two centers from September 2019 to December 2023. ISR was defined as ≥50% stenosis on follow-up Doppler ultrasound or CTA. Three predictive models were developed and defined as follows: Model A (Clinical), Model B (Clinical + Imaging), and Model C (Clinical + Imaging + Radiomics) using receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis. Results ISR occurred in 44 patients with a mean time interval of 11.3 months. Multivariate Cox regression analyses identified diabetes, fibrinogen, systolic blood pressure, calcified plaque volume, and pericarotid adipose tissue radiomics as independent predictors of ISR. The radiomics score, derived from 15 significant characteristics, outperformed conventional imaging markers. In the training set, Model C (AUC=0.881) significantly outperformed Model A (AUC=0.664) and Model B (AUC=0.840), with statistically significant differences (Model A vs Model C: P=0.001; Model B vs Model C: P=0.0246). This trend was consistent in the validation sets. Calibration curves showed good agreement between predicted and actual ISR probabilities, and decision curve analysis indicated that Model C provided greater net benefits. Conclusion The radiomic characteristics of pericarotid adipose tissue provide incremental value in predicting ISR after CAS and serve as a valuable biomarker for restenosis risk assessment.
- 1 March 2022
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (11) , 2789-2802
Targeting Diagnosis of High‐Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAFV600E Mutation
Objective High-risk papillary thyroid carcinoma (PTC) patients with BRAF mutation have lymph node and distant metastasis and poor prognosis. Therefore, this study aims to develop a targeted ultrasound contrast agent for the BRAF(V600E) mutation to screen high-risk PTC at early stage. Methods The targeted lipid nanobubbles carrying BRAF(V600E) antibody were prepared using thin film hydration-sonication and avidin-biotin binding methods. The physicochemical properties and stability of the targeted nanobubbles were detected by transmission electron microscopy, atomic force microscopy, and confocal laser scanning microscopy. The target binding abilities of the targeted nanobubbles in the PTC cells (B-CPAP) overexpressed mutant BRAF(V600E) were evaluated by immunofluorescence staining, quantitative real-time polymerase chain reaction, western blot, and fluorescence microscopy. After PTC tumor models overexpressed mutant BRAF(V600E) were established, the enhanced images of targeted lipid nanobubbles and untargeted lipid nanobubbles on PTC tumors in nude mice were observed using contrast-enhanced ultrasound imaging. Results The targeted lipid nanobubbles revealed uniform, round morphology, and good stability with a nanoscale size. Besides, BRAF(V600E) monoclonal antibody was observed to be combined on the surface of lipid nanobubbles. Furthermore, the targeted nanobubbles had a good targeting diagnosis ability in PTC cells with BRAF(V600E) overexpression. Moreover, the targeted nanobubbles had better ultrasound enhancement and peak intensity of the time-intensity curve (P < .001) in PTC tumors with BRAF(V600E) overexpression as compared to the untargeted lipid nanobubbles. Conclusion The targeted lipid nanobubbles carrying BRAF(V600E) antibody could be regarded as a potential targeted ultrasound contrast agent for the diagnosis of high-risk PTC.
- 1 March 2022
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (11) , 2789-2802
Targeting Diagnosis of High‐Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAFV600E Mutation
Objective High-risk papillary thyroid carcinoma (PTC) patients with BRAF mutation have lymph node and distant metastasis and poor prognosis. Therefore, this study aims to develop a targeted ultrasound contrast agent for the BRAF(V600E) mutation to screen high-risk PTC at early stage. Methods The targeted lipid nanobubbles carrying BRAF(V600E) antibody were prepared using thin film hydration-sonication and avidin-biotin binding methods. The physicochemical properties and stability of the targeted nanobubbles were detected by transmission electron microscopy, atomic force microscopy, and confocal laser scanning microscopy. The target binding abilities of the targeted nanobubbles in the PTC cells (B-CPAP) overexpressed mutant BRAF(V600E) were evaluated by immunofluorescence staining, quantitative real-time polymerase chain reaction, western blot, and fluorescence microscopy. After PTC tumor models overexpressed mutant BRAF(V600E) were established, the enhanced images of targeted lipid nanobubbles and untargeted lipid nanobubbles on PTC tumors in nude mice were observed using contrast-enhanced ultrasound imaging. Results The targeted lipid nanobubbles revealed uniform, round morphology, and good stability with a nanoscale size. Besides, BRAF(V600E) monoclonal antibody was observed to be combined on the surface of lipid nanobubbles. Furthermore, the targeted nanobubbles had a good targeting diagnosis ability in PTC cells with BRAF(V600E) overexpression. Moreover, the targeted nanobubbles had better ultrasound enhancement and peak intensity of the time-intensity curve (P < .001) in PTC tumors with BRAF(V600E) overexpression as compared to the untargeted lipid nanobubbles. Conclusion The targeted lipid nanobubbles carrying BRAF(V600E) antibody could be regarded as a potential targeted ultrasound contrast agent for the diagnosis of high-risk PTC.
- Open Access
- 1 May 2021
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 3991-4002
The Value of Sonography in Distinguishing Follicular Thyroid Carcinoma from Adenoma
Purpose: Differentiation between follicular thyroid carcinomas (FTCs) and follicular thyroid adenomas (FTAs) is difficult and the sonographic features of FTC are not yet fully established. The purpose of this study is to explore the sonographic features of FTC and the value of sonography in differentiating FTCs from FTAs. Patients and Methods: A total of 28 pathologically proven FTCs and 53 FTAs in 78 patients who were performed thyroid surgery were included in this retrospective study. The sonographic features of each tumor including an interrupted halo, satellite nodule(s) with or without halo ring, local irregularity of margin and cluster of grapes sign were evaluated. A mode image of FTC halo was built up in our study. The frequencies of the sonographic features were compared by chi-square test or Fisher exact test between FTCs and FTAs. The relative risk of malignancy was assessed by logistic regression analysis. Results: Logistic regression analysis showed that a thick, irregular and/or interrupted halo with or without satellite nodule(s), hypoechoic or marked hypoechoic echogenicity, a predominantly solid pattern, cluster of grapes sign, micro-or macro-calcifications, rim calcifications correlated with significant increases in relative risk for FTCs (odds ratio 11.48 (1.37– 96.56), 6.74 (1.05– 43.30), 17.51 (1.78– 172.53), 9.55 (1.44– 63.46), 9.36 (1.25– 70.15) and 17.45 (1.04– 292.65), respectively, p< 0.05). Two new sonographic features, an interrupted halo and satellite nodule(s) with or without halo ring, can only be found in FTCs. Conclusion: An interrupted halo and satellite nodule(s) with or without halo ring are specific sonographic features for FTCs. Sonography could play a role in differentiating follicular thyroid carcinoma from adenoma.
- 1 May 2021
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 3991-4002
Open AccessThe Value of Sonography in Distinguishing Follicular Thyroid Carcinoma from Adenoma
Purpose: Differentiation between follicular thyroid carcinomas (FTCs) and follicular thyroid adenomas (FTAs) is difficult and the sonographic features of FTC are not yet fully established. The purpose of this study is to explore the sonographic features of FTC and the value of sonography in differentiating FTCs from FTAs. Patients and Methods: A total of 28 pathologically proven FTCs and 53 FTAs in 78 patients who were performed thyroid surgery were included in this retrospective study. The sonographic features of each tumor including an interrupted halo, satellite nodule(s) with or without halo ring, local irregularity of margin and cluster of grapes sign were evaluated. A mode image of FTC halo was built up in our study. The frequencies of the sonographic features were compared by chi-square test or Fisher exact test between FTCs and FTAs. The relative risk of malignancy was assessed by logistic regression analysis. Results: Logistic regression analysis showed that a thick, irregular and/or interrupted halo with or without satellite nodule(s), hypoechoic or marked hypoechoic echogenicity, a predominantly solid pattern, cluster of grapes sign, micro-or macro-calcifications, rim calcifications correlated with significant increases in relative risk for FTCs (odds ratio 11.48 (1.37– 96.56), 6.74 (1.05– 43.30), 17.51 (1.78– 172.53), 9.55 (1.44– 63.46), 9.36 (1.25– 70.15) and 17.45 (1.04– 292.65), respectively, p< 0.05). Two new sonographic features, an interrupted halo and satellite nodule(s) with or without halo ring, can only be found in FTCs. Conclusion: An interrupted halo and satellite nodule(s) with or without halo ring are specific sonographic features for FTCs. Sonography could play a role in differentiating follicular thyroid carcinoma from adenoma.
- Open Access
- 26 February 2021
- Published by Wiley in Cancer Medicine
- Vol. 10 (6) , 1989-2002
The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross‐sectional study
Objective: Papillary thyroid microcarcinoma (PTMC) has a good prognosis and a long survival time, surgery is the common treatment including total thyroidectomy (TT) and unilateral lobectomy (LT), but recent studies showed that TT does not show an advantage over LT for PTMC in preventing cancer recurrence and reducing mortality. Given this, the health‐related quality of life (HRQoL) has become one of the important factors that physicians must consider when making treatment decisions. The aim of this study was to compare the HRQoL of patients between undergoing TT and LT.Methods: From October 2019 to December 2019, 69 PTMC patients were enrolled in our study, including 34 in the LT group and 35 in the TT group, respectively. We used three questionnaires which included the 36‐item short‐form health survey (SF‐36), thyroid cancer‐specific quality of life (THYCA‐QOL), and Fear of Progression Questionnaire‐Short Form (FoP‐Q‐SF) for each patient to evaluate their scores of HRQoL.Results: According to the SF‐36, the scores of the domain for the role limitation due to physical problems, emotional problems, and social function (RP, RE, and SF) as well as Physical Component Summary (PCS) and Mental Component Summary (MCS) showed a significant negative linear association between the LT group and TT group: RP (coefficient [coef]: −33.953 [confidence interval (CI) −51.187 to −16.720], p < 0.001, RE (coef: −21.633 [CI −39.500 to −3.766], p = 0.018), SF (coef: −10.169 [CI −19.586 to −0.752], p = 0.035)and PCS (coef: −10.571 [CI −17.768 to −3.373], p = 0.005), MCS (coef: −10.694 [CI −19.465 to −1.923], p = 0.018). The THYCA‐QOL showed that the scores of the TT group were higher than that of the LT group in the problem of scar (coef: 16.245 [CI 1.697 to 30.794], p = 0.029 according to the multivariate analysis), suggesting a higher level of complaint in the TT group. There was no statistically significant difference in the scores of FoP‐Q‐SF between the two groups.Conclusions: In patients with PTMC, LT offers an advantage over TT in terms of HRQoL, which supports the role of LT as an alternative strategy to TT.
- 26 February 2021
- Published by Wiley in Cancer Medicine
- Vol. 10 (6) , 1989-2002
Open AccessThe quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross‐sectional study
Objective: Papillary thyroid microcarcinoma (PTMC) has a good prognosis and a long survival time, surgery is the common treatment including total thyroidectomy (TT) and unilateral lobectomy (LT), but recent studies showed that TT does not show an advantage over LT for PTMC in preventing cancer recurrence and reducing mortality. Given this, the health‐related quality of life (HRQoL) has become one of the important factors that physicians must consider when making treatment decisions. The aim of this study was to compare the HRQoL of patients between undergoing TT and LT.Methods: From October 2019 to December 2019, 69 PTMC patients were enrolled in our study, including 34 in the LT group and 35 in the TT group, respectively. We used three questionnaires which included the 36‐item short‐form health survey (SF‐36), thyroid cancer‐specific quality of life (THYCA‐QOL), and Fear of Progression Questionnaire‐Short Form (FoP‐Q‐SF) for each patient to evaluate their scores of HRQoL.Results: According to the SF‐36, the scores of the domain for the role limitation due to physical problems, emotional problems, and social function (RP, RE, and SF) as well as Physical Component Summary (PCS) and Mental Component Summary (MCS) showed a significant negative linear association between the LT group and TT group: RP (coefficient [coef]: −33.953 [confidence interval (CI) −51.187 to −16.720], p < 0.001, RE (coef: −21.633 [CI −39.500 to −3.766], p = 0.018), SF (coef: −10.169 [CI −19.586 to −0.752], p = 0.035)and PCS (coef: −10.571 [CI −17.768 to −3.373], p = 0.005), MCS (coef: −10.694 [CI −19.465 to −1.923], p = 0.018). The THYCA‐QOL showed that the scores of the TT group were higher than that of the LT group in the problem of scar (coef: 16.245 [CI 1.697 to 30.794], p = 0.029 according to the multivariate analysis), suggesting a higher level of complaint in the TT group. There was no statistically significant difference in the scores of FoP‐Q‐SF between the two groups.Conclusions: In patients with PTMC, LT offers an advantage over TT in terms of HRQoL, which supports the role of LT as an alternative strategy to TT.